−0.05USD
−11.94 MUSD
198.96 MUSD
260.24 M
About MannKind Corporation
Sector
CEO
Michael E. Castagna
Headquarters
Danbury
Website
Employees (FY)
414
Founded
1991
ISIN
US56400P7069
FIGI
BBG000PPL3G9
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MNKD is 4.10 USD — it has increased by 1.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MannKind Corporation stocks are traded under the ticker MNKD.
MannKind Corporation is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for MannKind Corporation has a max estimate of 10.00 USD and a min estimate of 5.00 USD.
MNKD earnings for the last quarter are 0.01 USD whereas the estimation was −0.02 USD which accounts for 160.36% surprise. Estimated earnings for the next quarter are 0.00 USD. See more details about MannKind Corporation earnings.
MannKind Corporation revenue for the last quarter amounts to 51.25 M USD despite the estimated figure of 50.73 M USD. In the next quarter revenue is expected to reach 53.50 M USD.
Yes, you can track MannKind Corporation financials in yearly and quarterly reports right on TradingView.
Like other stocks, MNKD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MannKind Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 414.00 employees. See our rating of the largest employees — is MannKind Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MannKind Corporation EBITDA is 16.40 M USD, and current EBITDA margin is 8.24%. See more stats in MannKind Corporation financial statements.